Boston Therapeutics
Lawrence, US · Delaware corporation
Founders & leadership
CW
Carl W. RauschCEO
Board
CC
Conroy Chi-Heng ChengBoard director
CN
Colin NeillBoard director
AH
Alan HobermanBoard director
RE
Rom EliazChairman
Reported raises · per SEC filings
Form D private placements$10M disclosed across 2 rounds · 2016–2021
▶$8.4MraisedJul 2021 · 5 investors · BiotechnologyRule 506(b)
▶$8.4MraisedJul 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Conroy Chi-Heng ChengDirector
- David LudvigsonExecutive Officer, Director
- Offering amount
- $8.4M
- Amount sold
- $8.4M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedSep 2016 · 28 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedSep 2016 · 28 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Colin NeillDirector
- Conroy Chi-Heng ChengDirector
- Carl W. RauschExecutive Officer
- Alan HobermanDirector
- Rom EliazDirector
- Offering amount
- $2M
- Amount sold
- $1.6M
- Minimum investment
- $25K
- Sales commissions
- $160K
- Proceeds to insiders
- $100K
- Placement agents
- Maxim Group, LLC
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Boston Therapeutics raised?
- Boston Therapeutics has disclosed $10M raised across 2 rounds.
- Where is Boston Therapeutics headquartered?
- Boston Therapeutics is headquartered in Lawrence, US.